Lykiri, in the Amarin message board, Biobill is excited FDA has opened up a online drug review computer program that one can float trial data, and looks like approval can be instantaneous. Do you think LP is working with the FDA some sort like this. I think so. But Ex not. We never know. While we have enough data for a trial that is run for more than a decade with no safety issue and potentially solid efficacy, any thing is possible.
News 
Market Data 
Discover 
